Real-Time Blood Count Analyzing Company Wins $3 Million European Commission Grant
Israel-based PixCell Medical Technologies develops a portable device that can analyze 20 standard blood count parameters in five minutes
For daily updates, subscribe to our newsletter by clicking here.
Established in 2008, privately-held PixCell develops portable medical diagnostic devices for use in point-of-care testing. Its lead product, a kettle-sized device called HemoScreen, can analyze 20 standard blood count parameters including hemoglobin, platelet and white blood cell count within five minutes.
The technology, which PixCell states has been validated in three clinical studies in the U.S., is based on a lab-on-a-cartridge concept: a single-use, disposable cartridge that includes storage compartments, mixing chambers, and a microfluidic chip that serves as both a reactor and an analysis chamber. This enables the execution of complex lab procedures without user intervention.
The device has received a CE Mark (European conformity) permission, and the company expects it to be cleared by the U.S. Food and Drug Administration in 2018.
PixCell stated it will use the funding for additional clinical trials and to accelerate HemoScreen’s commercialization. The company is currently developing the technology for additional diagnostic products for hemostatic and immuno-based disorders.